Jakavi 5mg Tablet

• Treat blood disorders such as chronic idiopathic myelofibrosis and polycythemia.

Every medication has several side effects some are resolved on their own and some need proper medical attention to treat. Common ones include:

• Low red and white blood cell counts
• Low platelet counts
• Dizziness, headache
• Bruising
• Diarrhea
• Infections including viral infections
• Swelling in the face and body
• Fatigue or tiredness

• Severe infections like hepatitis B
• Anemia
• Bleeding

Jakavi 5mg tablet should be taken with or without food at the fixed time everyday to enhance the effectiveness of the medication. Proper dosage and duration is correctly administered by the healthcare professional, do not self administered. To get the most benefit, always follow the recommended dosage and duration and consult your doctor if you experience any of the side effects to ensure safe and effective treatment option.

The medicine targets and inhibits JAK1 and JAK2 enzyme which plays a key role in immune response signaling, blood cell production and inflammation. By blocking these signals, jakavi 5mg tablet helps calm abnormal cell growth in myeloproliferative disorders and reduces inflammatory activity. The tablet is used as a first line therapy that stops the growth of cancer cells and protect the body from spreading tumor cells.

• Savoia, M., Pugliese, S., Teseo, G., Pennacchia, A., Ricci, M., Ronca, S., ... & D’arpino, A. (2021). 3PC-067 Key role of the hospital pharmacy in a non-profit study involving ruxolitinib 5 mg CPS: implementation and quality assurance of an investigational manufacturing product.
• Plosker, G. L. (2015). Ruxolitinib: a review of its use in patients with myelofibrosis. Drugs, 75(3), 297-308.
• Torrente-López, A., Hermosilla-Fernández, J., Hernández-Jiménez, J., Cabeza, J., Salmerón-García, A., & Navas, N. (2021). 3PC-065 Impact of light stress on the isoform profile of nivolumab (Opdivo) in opened vials estimated by (RP) UHPLC-UV-(HESI/Orbitrap)-MS.
• Witte, T. (2022). Januskinaseinhibitoren. Zeitschrift für Rheumatologie, 81(2), 94-99.
• WAEC, N., & a Doctor, C. Jakavi 5mg Tablet 14? S.